mTOR inhibition improves mitochondria function/biogenesis and delays cardiovascular aging in kidney transplant recipients with chronic graft dysfunction

CVD remains the major cause of mortality with graft functioning in Kidney transplant recipients (KTRs), with an estimated risk of CV events about 50-fold higher than in the general population. Many strategies have been considered to reduce the CV risk such as the use of mTOR inhibitors. We evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Infante, Barbara, Bellanti, Francesco, Correale, Michele, Pontrelli, Paola, Franzin, Rossana, Leo, Serena, Calvaruso, Martina, Mercuri, Silvia, Netti, Giuseppe Stefano, Ranieri, Elena, Brunetti, Natale Daniele, Grandaliano, Giuseppe, Gesualdo, Loreto, Serviddio, Gaetano, Castellano, Giuseppe, Stallone, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034974/
https://www.ncbi.nlm.nih.gov/pubmed/33758105
http://dx.doi.org/10.18632/aging.202863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034974/
https://www.ncbi.nlm.nih.gov/pubmed/33758105
http://dx.doi.org/10.18632/aging.202863

Ejemplares similares